The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells
Barbara Peter(University of Veterinary Medicine Vienna), Peter Valent(Medical University of Vienna), Michael Willmann(University of Veterinary Medicine Vienna), Winfried F. Pickl(Medical University of Vienna), Gregor Hoermann(University of Freiburg), Emir Hadzijusufovic(University of Veterinary Medicine Vienna), Karoline V. Gleixner(Medical University of Vienna), Matthias Mayerhofer(Medical University of Vienna), Sabine Cerny‐Reiterer(Medical University of Vienna), Gregor Eisenwort(Ludwig Boltzmann Institute for Cardiovascular Research), Wolfgang R. Sperr(Medical University of Vienna), Karina Schuch(Medical University of Vienna), Gabriele Stefanzl(Medical University of Vienna), Sigrid Baumgartner(Medical University of Vienna), Michael Kundi(Medical University of Vienna)
Cited by 37
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496